
Dr. Piero Antuono, Professor of Neurology and Pharmacology at the Medical College of Wisconsin in Milwaukee, and a leading Alzheimer's researcher
Piero Antuono, M.D., leading Alzheimer's researcher, updates research on that disease and discusses the use of atypical anti-psychotics such as Risperdal in Alzheimer‘s patients
Etopia Medical News #137
Milwaukee, Wisconsin
April 24, 2007
By Marc Strassman
This page and its contents are copyright © 2007 by Etopia Media News Networks. All rights in all media reserved. Dr. Piero Antuono is Professor of Neurology, Pharmacology, and Toxicology at the at the
Medical College of Wisconsin in Milwaukee and is the Director of the Dementia Research Center there. He is a leading Alzheimer's researcher.
Reporter
Etopia Medical News
World Chat Show Channel
Human Rights Channel
Nuclear Power Channel
Solar World
Etopia Environment and Energy News
Etopia News
The Medical College of Wisconsin Dementia Research Center includes a clinic for patients with memory loss, programs for the development of new drugs for dementias, and an autopsy program dedicated to the study of Alzheimer's Disease.
Dr. Antuono first spoke with Etopia Medical News on November 29, 2004, about the nature, causes, treatments, and prevention of Alzheimer's disease, a neurological affliction now affecting millions of Americans and their families and expected to affect many more in the years to come.
Dr. Antuono returned today to speak with Etopia Medical News reporter Marc Strassman about the latest research into, and treatment options for, Alzheimer’s and also talked about recent research from the U.K. linking the use of neuroleptic drugs in Alzheimer’s patients with pre-mature death.